Tumor-associated macrophages: function, phenotype, and link to prognosis in human lung cancer.
暂无分享,去创建一个
[1] Shu-Min Lin,et al. Tumor‐associated macrophages correlate with response to epidermal growth factor receptor‐tyrosine kinase inhibitors in advanced non‐small cell lung cancer , 2012, International journal of cancer.
[2] D. Gabrilovich,et al. Coordinated regulation of myeloid cells by tumours , 2012, Nature Reviews Immunology.
[3] A. Mantovani,et al. Cancer-related inflammation: common themes and therapeutic opportunities. , 2012, Seminars in cancer biology.
[4] T. Chatila,et al. T cell receptor (TCR)-transgenic CD8 lymphocytes rendered insensitive to transforming growth factor beta (TGFβ) signaling mediate superior tumor regression in an animal model of adoptive cell therapy , 2012, Journal of Translational Medicine.
[5] S. H. van der Burg,et al. Identification and manipulation of tumor associated macrophages in human cancers , 2011, Journal of Translational Medicine.
[6] Alexandros Nikolaou,et al. Mononuclear phagocyte heterogeneity in cancer: different subsets and activation states reaching out at the tumor site. , 2011, Immunobiology.
[7] Haiquan Chen,et al. Tumor-associated macrophages provide a suitable microenvironment for non-small lung cancer invasion and progression. , 2011, Lung cancer.
[8] Juan Gao,et al. M2-Polarized tumor-associated macrophages are associated with poor prognoses resulting from accelerated lymphangiogenesis in lung adenocarcinoma , 2011, Clinics.
[9] G. Natoli,et al. Transcriptional regulation of macrophage polarization: enabling diversity with identity , 2011, Nature Reviews Immunology.
[10] S. H. van der Burg,et al. M2 Macrophages Induced by Prostaglandin E2 and IL-6 from Cervical Carcinoma Are Switched to Activated M1 Macrophages by CD4+ Th1 Cells , 2011, The Journal of Immunology.
[11] S. H. van der Burg,et al. Activation of Tumor-Promoting Type 2 Macrophages by EGFR-Targeting Antibody Cetuximab , 2011, Clinical Cancer Research.
[12] Y. Daaka,et al. Aberrant PGE₂ metabolism in bladder tumor microenvironment promotes immunosuppressive phenotype of tumor-infiltrating myeloid cells. , 2011, International immunopharmacology.
[13] Mayte Suárez-Fariñas,et al. Tumor-associated macrophages in the cutaneous SCC microenvironment are heterogeneously activated. , 2011, The Journal of investigative dermatology.
[14] Haiquan Chen,et al. Increased IL-10 mRNA expression in tumor-associated macrophage correlated with late stage of lung cancer , 2011, Journal of experimental & clinical cancer research : CR.
[15] M. Ewen,et al. CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3. , 2011, Cancer cell.
[16] T. Wynn,et al. Obstacles and opportunities for understanding macrophage polarization , 2011, Journal of leukocyte biology.
[17] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[18] F. Heppner,et al. M2 polarized macrophages and giant cells contribute to myofibrosis in neuromuscular sarcoidosis. , 2011, The American journal of pathology.
[19] H. Lockstone,et al. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses , 2011, Nature Immunology.
[20] T. Ishikawa,et al. Prostaglandin E₂ signaling and bacterial infection recruit tumor-promoting macrophages to mouse gastric tumors. , 2011, Gastroenterology.
[21] J. Vieweg,et al. Pivotal Advance: Tumor‐mediated induction of myeloid‐derived suppressor cells and M2‐polarized macrophages by altering intracellular PGE2 catabolism in myeloid cells , 2010, Journal of leukocyte biology.
[22] A. Ochiai,et al. Stromal Macrophage Expressing CD204 is Associated with Tumor Aggressiveness in Lung Adenocarcinoma , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[23] A. Mantovani,et al. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm , 2010, Nature Immunology.
[24] L. Coussens,et al. Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression. , 2010, Cancer research.
[25] M. Pedriali,et al. CD8+ T cells expressing IL-10 are associated with a favourable prognosis in lung cancer. , 2010, Lung cancer.
[26] P. De Baetselier,et al. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. , 2010, Cancer research.
[27] P. Bradding,et al. Tumour necrosis factor-alpha expression in tumour islets confers a survival advantage in non-small cell lung cancer , 2010, BMC Cancer.
[28] S. Gordon,et al. Alternative activation of macrophages: mechanism and functions. , 2010, Immunity.
[29] Jeffrey W. Pollard,et al. Macrophage Diversity Enhances Tumor Progression and Metastasis , 2010, Cell.
[30] Luigi Naldini,et al. Elusive identities and overlapping phenotypes of proangiogenic myeloid cells in tumors. , 2010, The American journal of pathology.
[31] Alberto Mantovani,et al. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. , 2010, Current opinion in immunology.
[32] Michael C. Ostrowski,et al. An ets2-driven transcriptional program in tumor-associated macrophages promotes tumor metastasis. , 2010, Cancer research.
[33] Lunxu Liu,et al. The number and microlocalization of tumor-associated immune cells are associated with patient's survival time in non-small cell lung cancer , 2010, BMC Cancer.
[34] P. Bradding,et al. Chemokine receptor expression in tumour islets and stroma in non-small cell lung cancer , 2010, BMC Cancer.
[35] Lunxu Liu,et al. The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time , 2010, BMC Cancer.
[36] Jeffrey W Pollard,et al. Gene Expression Analysis of Macrophages That Facilitate Tumor Invasion Supports a Role for Wnt-Signaling in Mediating Their Activity in Primary Mammary Tumors , 2009, The Journal of Immunology.
[37] Gisen Kim,et al. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis , 2009, Nature Immunology.
[38] Hua Yu,et al. STATs in cancer inflammation and immunity: a leading role for STAT3 , 2009, Nature Reviews Cancer.
[39] N. Mukaida,et al. Blockade of a chemokine, CCL2, reduces chronic colitis-associated carcinogenesis in mice. , 2009, Cancer research.
[40] T. Dønnem,et al. The prognostic value of intraepithelial and stromal innate immune system cells in non‐small cell lung carcinoma , 2009, Histopathology.
[41] Ruth J. Muschel,et al. A Distinct Macrophage Population Mediates Metastatic Breast Cancer Cell Extravasation, Establishment and Growth , 2009, PloS one.
[42] L. Coussens,et al. CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. , 2009, Cancer cell.
[43] I. Weissman,et al. CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis , 2009, Cell.
[44] Jing Xu,et al. Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1 , 2009, The Journal of experimental medicine.
[45] P. Allavena,et al. Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation. , 2009, Human immunology.
[46] G. Kuttan,et al. Role of macrophages in tumour progression. , 2009, Immunology letters.
[47] G. Nuovo,et al. Granulocyte macrophage colony-stimulating factor inhibits breast cancer growth and metastasis by invoking an anti-angiogenic program in tumor-educated macrophages. , 2009, Cancer research.
[48] P. Bradding,et al. Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival , 2009, European Respiratory Journal.
[49] J. Edwards,et al. Exploring the full spectrum of macrophage activation , 2008, Nature Reviews Immunology.
[50] A. Gemma,et al. Predominant infiltration of macrophages and CD8+ T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer , 2008, Cancer.
[51] Mikala Egeblad,et al. Visualizing stromal cell dynamics in different tumor microenvironments by spinning disk confocal microscopy , 2008, Disease Models & Mechanisms.
[52] Craig Murdoch,et al. The role of myeloid cells in the promotion of tumour angiogenesis , 2008, Nature Reviews Cancer.
[53] P. Allavena,et al. Cancer-related inflammation , 2008, Nature.
[54] R. Ádány,et al. Tumor‐infiltrating myeloid‐derived suppressor cells are pleiotropic‐inflamed monocytes/macrophages that bear M1‐ and M2‐type characteristics , 2008, Journal of leukocyte biology.
[55] Hsuan-Yu Chen,et al. TREM-1 expression in tumor-associated macrophages and clinical outcome in lung cancer. , 2008, American journal of respiratory and critical care medicine.
[56] P. Allavena,et al. The Yin‐Yang of tumor‐associated macrophages in neoplastic progression and immune surveillance , 2008, Immunological reviews.
[57] Jae Hyun Kim,et al. High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer , 2008, British Journal of Cancer.
[58] H. Gascan,et al. Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells. , 2007, Blood.
[59] M. Pedriali,et al. Macrophage expression of interleukin-10 is a prognostic factor in nonsmall cell lung cancer , 2007, European Respiratory Journal.
[60] Jiasen Cheng,et al. Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes. , 2007, Blood.
[61] C. Lewis,et al. Inflammation and breast cancer. Microenvironmental factors regulating macrophage function in breast tumours: hypoxia and angiopoietin-2 , 2007, Breast Cancer Research.
[62] Yarong Wang,et al. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. , 2007, Cancer research.
[63] A. Bikfalvi,et al. Tumor angiogenesis , 2020, Advances in cancer research.
[64] J. Pollard,et al. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. , 2006, Cancer research.
[65] P. De Baetselier,et al. Identification of a common gene signature for type II cytokine-associated myeloid cells elicited in vivo in different pathologic conditions. , 2006, Blood.
[66] S. Rosenberg,et al. Adoptive immunotherapy for cancer: building on success , 2006, Nature Reviews Immunology.
[67] Alberto Mantovani,et al. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. , 2006, European journal of cancer.
[68] T. Kawabe,et al. Expression of macrophage-derived chemokine (MDC)/CCL22 in human lung cancer , 2006, Cancer Immunology, Immunotherapy.
[69] T. Ottenhoff,et al. Phenotypic and functional profiling of human proinflammatory type‐1 and anti‐inflammatory type‐2 macrophages in response to microbial antigens and IFN‐γ‐ and CD40L‐mediated costimulation , 2006, Journal of leukocyte biology.
[70] J. Pollard,et al. Distinct role of macrophages in different tumor microenvironments. , 2006, Cancer research.
[71] T. Waldmann. Effective cancer therapy through immunomodulation. , 2006, Annual review of medicine.
[72] K. O'Byrne,et al. Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[73] S. Gordon,et al. Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.
[74] B. Dahal,et al. Macrophage galactose‐type C‐type lectins as novel markers for alternatively activated macrophages elicited by parasitic infections and allergic airway inflammation , 2005, Journal of leukocyte biology.
[75] A. Mantovani,et al. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. , 2005, Cancer cell.
[76] Yi-Chen Lin,et al. Tumor-associated macrophages: the double-edged sword in cancer progression. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[77] J. Pollard,et al. A Paracrine Loop between Tumor Cells and Macrophages Is Required for Tumor Cell Migration in Mammary Tumors , 2004, Cancer Research.
[78] S. Rosenberg,et al. Cancer immunotherapy: moving beyond current vaccines , 2004, Nature Medicine.
[79] George Coukos,et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival , 2004, Nature Medicine.
[80] J. Brayer,et al. Arginase I Production in the Tumor Microenvironment by Mature Myeloid Cells Inhibits T-Cell Receptor Expression and Antigen-Specific T-Cell Responses , 2004, Cancer Research.
[81] F. Balkwill. Cancer and the chemokine network , 2004, Nature Reviews Cancer.
[82] T. Manabe,et al. Clinical significance of VEGF-C status in tumour cells and stromal macrophages in non-small cell lung cancer patients , 2004, British Journal of Cancer.
[83] J. Pollard. Tumour-educated macrophages promote tumour progression and metastasis , 2004, Nature Reviews Cancer.
[84] A. Kargı,et al. Association of macrophages, mast cells and eosinophil leukocytes with angiogenesis and tumor stage in non-small cell lung carcinomas (NSCLC). , 2004, Lung cancer.
[85] T. Waldmann,et al. Immunotherapy: past, present and future , 2003, Nature Medicine.
[86] Jeremy J. W. Chen,et al. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[87] E. Kay,et al. Infiltrating immune cells, but not tumour cells, express FasL in non‐small cell lung cancer: No association with prognosis identified in 3‐year follow‐up , 2003, International journal of cancer.
[88] P. Allavena,et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. , 2002, Trends in immunology.
[89] Noam Brown,et al. The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies , 2002, The Journal of pathology.
[90] Andrew V. Nguyen,et al. Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy , 2001, The Journal of experimental medicine.
[91] I. Takanami,et al. Tumor-Associated Macrophage Infiltration in Pulmonary Adenocarcinoma: Association with Angiogenesis and Poor Prognosis , 1999, Oncology.
[92] Y. Vodovotz,et al. Immunocytochemical localization of latent transforming growth factor‐β1 activation by stimulated macrophages , 1999, Journal of cellular physiology.
[93] A. Harris,et al. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. , 1996, Cancer research.
[94] D. Hanahan,et al. Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.
[95] I. Fidler,et al. Recognition and destruction of neoplastic cells by activated macrophages: discrimination of altered self. , 1988, Biochimica et biophysica acta.
[96] I. M. Neiman,et al. [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.